Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
SGLT2 Inhibitors Linked to Improved Kidney Outcomes in Type 2 Diabetes
February 2026
A nationwide comparative study shows SGLT2 inhibitors lower long-term chronic kidney disease and acute kidney injury risk compared with GLP-1 receptor agonists.
Read more
27 Apr 2025
Dual Index Approach Enhances Detection of Functional Decline in Patients on Haemodialysis
A new study highlights how combining the Geriatric Nutritional Risk Index (GNRI) and Modified Creatinine Index (mCI) significantly improves prediction of functional dependence in hemodialysis patients.
25 Apr 2025
AI Model Predicts 30-Day Readmission After Kidney Transplant
Researchers developed a machine learning model combining predictive power and interpretability to help manage hospital readmissions after kidney transplants.
27 Mar 2025
GLP-1 Use After Kidney Transplant Linked to Nearly 50% Lower Graft Loss
GLP-1 receptor agonists were associated with nearly 50% lower graft loss and significantly reduced mortality in kidney transplant recipients with diabetes, according to new research.
27 Mar 2025
Patients on Dialysis Facing Food Insecurity More Prone to Fluid-Related Complications
Food insecurity may not raise overall hospitalization rates for adults on dialysis, but it triples the risk of fluid or electrolyte-related admissions, especially in younger patients, new research suggests.
1 Mar 2025
Hyponatremia After Thiazide Use Linked to Increased Mortality
Patients who develop hyponatremia after beginning thiazide diuretics face nearly double the risk of death, according to a new study. The research highlights the need for careful monitoring of sodium levels in hypertensive patients taking these common medications.
27 Feb 2025
SGLT2 Inhibitors Lower Kidney Failure Risk in Advanced Diabetes
A large-scale study in Taiwan has revealed that SGLT2 inhibitors significantly lower the risk of kidney failure in patients with Type 2 diabetes and CKD stage 5.
27 Feb 2025
Body Size May Affect Kidney Donor Eligibility, Study Finds
A new study from the University of Minnesota suggests that differences in how kidney function is measured in living kidney donors could have significant long-term implications.
31 Jan 2025
Study Links Acute Kidney Injury to Increased Dementia Risk in Older Adults
A study using data from the SPRINT trial has linked even mild, reversible acute kidney injury (AKI) to a significantly higher risk of dementia and mild cognitive impairment (MCI) in older adults with cardiovascular risk factors.
Loading posts...
« Previous
1
2
3
4
5
6
…
22
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View